J10.22036 - Volume 7 - Issue 1 - Pages 7-13
J10.22036 - Volume 7 - Issue 1 - Pages 7-13
J10.22036 - Volume 7 - Issue 1 - Pages 7-13
1. INTRODUCTION
Considerable efforts have been devoted to the design and ligands, 1,10-phenanthroline (Phen) and its derivatives are
synthesis of cocrystals, in other words crystals composed the subjects of special attention in ternary lanthanide
of two or more distinct molecules in a crystalline lattice, complexes.28-33 1,10-Phenanthroline is a biologically
owing to their importance in the pharmaceutical important ligand, and some of its metal complexes
industry.1-3 These compounds show great potential in exhibit effective activityagainst various strains of
serving as new antitumor agents.4,5 The coordination microorganisms.34,35 In this study, the novel cocrystal
mode and orientation of the donor groups of organic Copper-Cerium (C) based on 1,10-phenanthroline, was
ligands play an important role in controlling coordination synthesized by condensation of Ce(NO3)3.6H2O,
compound structures.6 Copper(II) chelates have been Cu(ClO4), and 1,10- phenanthroline in ethanol solvent.
found to interact with biological systems and exhibit The resultant Cocrystal was identified via IR
antineoplastic, antibacterial, antifungal, and anticancer spectroscopy, elemental analysis, and X-ray
activity.7-14 Some Cu(II) N/S, O/N, and N-donor chelators Crystallography. In addition, the antimicrobial activity
are good anticancer agents due to their strong binding against S. aureus, S. saprophyticus, and P. aeruginosa,
ability with DNA base pairs.15-20 Lanthanide complexes was studied by the disk-diffusion method.
are widely used as optical and magnetic materials,
catalysts, and useful in biomedicine.21-24 Besides, it is well 2. EXPERIMENTAL
known that lanthanides behave as typical hard acids and Materials and physical methods
prefer donor atoms with the preference O > N > S and F > All chemicals and solvents such as 1,10-phenanthroline,
Cl.21 An overview of the literature shows a wide range of Ce(NO3)3.6H2O, Cu(ClO4)2, acetonitrile, methanol, and ethanol
antibacterial activity of Cerium(III) compounds.25,26 were of reagent grade and obtained without further purification.
Infrared (IR) spectra were recorded on a Shimadzu FT-IR 8400S
The cream or aqueous solution of Ce compounds has been (Japan) in the range 400-4000 cm_1 using KBr pellets. Melting
widely used in the antibacterial treatment of burn wounds. points were measured on an Electrothermal 9100 apparatus.
Cerium materials cannot penetrate the cell membrane of Electronic spectra were recorded by Varian, Cary 100 UV-Vis
mammals and no toxicity has been observed with Ce.27 A spectrophotometer in the range of 200-800 nm.
literature survey reveals that among the different neutral
Inorganic Chemistry Research Article
X-Ray structure analysis the compound indicate that nitrogen atoms of the Phen
Single-crystal X-ray diffraction measurements were carried out group participate in coordination with the Ce(III) ion
on a STOE IPDS 2T image plate diffractometer system equipped (Figure 1).40
with a sealed Mo X-ray tube and a graphite monochromator
crystal (λ(MoKα) = 71.073 pm). Data reduction and numerical
absorption correction were carried out with STOE X-AREA
software.36 All structures were solved by direct methods using
SHELXS-2018 and refined with SHELXL-2018 37 using
WinGX38 as a graphical frontend. CCDC 2285429 contains
the supplementary crystallographic data for this paper. This
data can be obtained free of charge via
http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the
CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: +44
1223 336033; E-mail: deposit@ccdc.cam.ac.uk).
Antimicrobial Test
The compounds were dissolved in DMSO at the concentration of
1000, 500, and 100 µg/mL and used for antibacterial evaluation.
The solution was UV-sterilized and used for disk diffusion.
Paper discs (6.5 mm) were impregnated with 40 µL of the
sample and the solvent was evaporated under a safety cabinet at
room temperature. The bacterial suspension's turbidity was
compared and equalized with the Mac-Farland 0.5 standard. Figure 1. FT-IR spectrum of (a) Phen, and (b) cocrystal C.
Then, the suspension was spread over a Muller Hinton agar plate
with sterile swab. The plates were incubated at 35 oC overnight Ultraviolet spectra
and the inhibition zone (IZ) was measured. The antibacterial UV spectra of the Phen and cocrystal C are depicted in
effect of C, Phen, and metal salts by using the disk diffusion DMSO solution (1.0 × 10-5 mol/L) in the wavelength
method at 10, 20, and 40 µg/D (microgram per paper discs) range of 200–400 nm. The C and Phen have strong π→π*
concentrations was investigated against two bacteria (S. aureus, transition absorption. The maximum absorption band at
S.saprophyticus) and one gram-negative bacterium 266 nm for the cocrystal C is similar to that in the Phen,
(P.aeruginosa). DMSO solvent as a negative control and
which indicates that the formation of Ce-N has no
antibiotics Gentamicin and Vancomycin as positive control were
considered that microbial shadow created around the disks is the conspicuous influence on the UV absorption of the Phen.
indicative antibacterial effect of compounds. By changing the solvent to ethanol, the absorption
spectrum of Phen and C exhibit two relatively strong
Synthesis of [Cu(Phen)3][Ce(Phen)(NO3)5] (C) absorption peaks at 230 and 266 nm, which can be
To a solution of 1,10-phenanthroline (Phen) (0.5 mmol, 0.090 g) assigned to the π→π* transition of the Phen ring
in 10 mL acetonitrile, Ce(NO3)3.6H2O (0.25 mmol, 0.108 g) and (Figure 2).
Cu(ClO4)2(0.25 mmol, 0.092g) in methanolic solution was The solvatochromic behavior of cocrystal C is the shift of
added and the resulting mixture was then stirred 72h at room the π→π* band wavelength due to the presence of solvent
temperature. Green single crystals were obtained by with different polarity and interaction between the solute
recrystallization from ethanol solution at room temperature.
and solvent molecules.
Yield 30%, M.p. 229–230 °C; Anal. Calc. for
C48H32CeCuN13O15: C, 46.69; H, 2.61; N, 14.74%. Found: C,
46.75; H, 2.65; N, 14.68%. IR (KBr, cm−1): 3070 (s), 1620 (s),
1585 (s), 1442 (w), 1334 (w), 1218 (s), 1141 (s), 1099 (s), 1037
(s), 848 (s), 725 (s), 636 (s). UV–Vis in DMSO: λmax 266 nm.
Description of the molecular structure of cocrystal (C) other reported compounds.8 In the asymmetric unit of
Green crystals of (C) were obtained after slow [Ce(Phen)(NO3)5]2-, the central Ce ion is 12-coordinated,
evaporation at room temperature (see Experimental
section). Crystallographic data and details of the X-ray
analysis are given in Table 1, and the defined dihedral
angles and distances of (C) are summarized in Table 2.
Figure 7. 2D fingerprint plots, full and resolved into O...H, H…H, C...H, C..C, C...O and N...H contacts, showing.
three orders of magnitude smaller than those of the phen therapeutic agents.
and the lanthanum salt (La(NO3)3·6H2O). The results
suggest that the La(III) complex has strong antibacterial ACKNOWLEDGMENTS
activity against gram-positive and gram-negative bacteria, The authors would like to acknowledge the financial
implying that the La(III) complex may become a broad- support of Lorestan University for this research under
spectrum antibacterial agent.44 grant number 1401-4-05-3-20-1403.
There are specific reports of Cu(II) complexes where the
presence of the copper ion appears to enhance the AUTHOR INFORMATION
antimicrobial properties of ligand.45 Corresponding Author
The biological activity of metal compounds may be Niloufar Dorosti: Email: nilufardorosti@gmail.com,
explained based on the effect of metal ion on the cell ORCID: 0000-0003-3822-8214
metabolism.8 The antimicrobial activity of C will increase
along with the rise of their concentration in the range of Author(s)
10–40 µg/D. In contrast, the antimicrobial activity for Maryam Pass, Daniel Fuhrmann
metal salts in the same concentrations is low. The
simultaneous presence of Phen, Cu(II), and Ce(III) in
cocrystal C, may be the reason for the potent REFERENCES
antimicrobial activity of this compound. Therefore, the 1. K. Moradifard, Z. Derikvand, A. Azadbakht,
result indicates that C has vigorous biological activities Crystallogr. Rep. 2019, 64, 1038-1042.
which require further research and study to make a useful 2. M. Karimi-Jafari, L. Padrela, G. M. Walker, D. M.
application in different industries like medicine. Croker, Cryst. Growth Des. 2018, 18, 6370-6387.
3. C. Zhang, Y. Xiong, F. Jiao, M. Wang, H. Li, Cryst.
Growth Des. 2019, 19, 1471-1478.
4. CONCLUSIONS
4. H. Yu, B. Zhang, W. Xing, M. Liu, D. Yang, G. He, F.
In summary, Cu(II)/Ce(III) cocrystal were successfully
Wang, L. Zhang, N. Gong, Y. Lu, Cryst. Growth Des.
synthesized by the reaction of Ce(III)and Cu(II) ions with
2022, 22, 7195-7206.
1,10-phen in ethanol solvent at room temperature. The
5. A. Zochedh, M. Priya, A. Shunmuganarayanan, A. B.
crystal structures showed that Phen is coordinated to the
Sultan, T. Kathiresan, J. Mol. Struct. 2023, 1282,
metal centers in a bidentate fashion. Furthermore, the in
135113-135132.
vitro antimicrobial activity was evaluated, and the
6. Z. Derikvand, A. Azadbakht, B. Notash, Inorg. Nano-
antibacterial effect was conducted by the disk diffusion
Met. 2018, 48, 196-202.
method, the results of the antibacterial experiments
7. Y. Xu, Y. Shi, F. Lei, L. Dai, Carbohydr. Polym. 2020,
showed that the cocrystal had high activity against the
230, 115671-115695.
P.aeruginosa and S. aureus bacteria. The simultaneous
8. D. Inci, R. Aydin, T. Sevgi, Y. Zorlu, E. Demirkan, J.
presence of Phen, Cu(II), and Ce(III), in the studied
Coord. Chem. 2017, 70, 512-543.
cocrystal, maybe the reason for its potent antimicrobial
9. A. Abbaszadeh, N. Safari, V. Amani, B. Notash, F.
activity. Results demonstrate that the synthesized
Raei, F. Eftekhar, IJCCE 2014, 33, 1-13.
cocrystal with biological properties might help prevent the
10. K. Neethu, S. Sivaselvam, M. Theetharappan, J.
progress of various diseases and the development of novel
Ranjitha, N. Bhuvanesh, N. Ponpandian, M.
Neelakantan, M. Kaveri, Inorganica Chim. Acta 2021, 30. Y. Yang, Z. Zhou, Z. -Z. Wei, Q. -P. Qin, L. Yang, H.
524, 120419-120434. Liang, Dalton Trans. 2021, 50, 5828-5834.
11. K. Ghazal, S. Shoaib, M. Khan, S. Khan, M. K. Rauf, 31. M. Kosińska-Pezda, L. Zapała, U. Maciołek, Ł.
N. Khan, A. Badshah, M. N. Tahir, I. Ali, J. Mol. Byczyński, E. Woźnicka, W. Zapała, JAAP 2021, 159,
Struct. 2019, 1177, 124-130. 105293-105251.
12. Q. Peña, G. Sciortino, J. -D. Maréchal, S. Bertaina, A. 32.T. Madanhire, M. C. Pereira, H. Davids, E. C. Hosten,
J. Simaan, J. Lorenzo, M. Capdevila, P. Bayón, O. A. R. Abrahams, Polyhedron. 2020, 189, 114713-
Iranzo and Ò. Palacios, Inorg. Chem. 2021, 60, 2939- 114728.
2952. 33. T. Madanhire, H. Davids, M. C. Pereira, E. C. Hosten,
13. N. L. Stevanović, I. Aleksic, J. Kljun, S. Skaro A. R. Abrahams, Polyhedron. 2020, 185, 114583-
Bogojevic, A. Veselinovic, J. Nikodinovic-Runic, I. 114594.
Turel, M. I. Djuran, B. Đ. Glišić, J. Pharm. 2020, 14, 34. N. S. Ng, M. J. Wu, J. R. Aldrich-Wright, J. Inorg.
24-44. Biochem. 2018, 180, 61-68.
14. A. Jaafar, A. Fix‐Tailler, N. Mansour, M. Allain, W. 35. M. Abaszadeh, R. Hosseinzadeh, M. Tajbakhsh, S.
N. Shebaby, W. H. Faour, S. Tokajian, A. Ghasemi, J. Mol. Struct. 2022, 1261, 132832-132847.
El‐Ghayoury, D. Naoufal, J. P. Bouchara, Appl. 36. STOE & Cie GmbH. X-Area Version 1.70; STOE &
Organomet. Chem. 2020, 34, 5988-6001. Cie GmbH: Darmstadt, Germany, 2014.
15. Y. A. Gur'eva, O. A. Zalevskaya, O. G. Shevchenko, 37. G. M. Sheldrick, Acta Crystallogr. A. 2008, 64, 112-
P. A. Slepukhin, V. A. Makarov, A. V. Kuchin, RSC 122.
Adv. 2022, 12, 8841-8851. 38. L. J. Farrugia, J. Appl. Crystallogr. 2012, 45, 849-854.
16. S. Sobhani, M. Pordel, S. A. Beyramabadi, J. Mol. 39. D. S. Yanick Gaelle, M. Ondoh Agwara, D. M.
Struct. 2019, 1175, 677-685. Yufanyi, J. Nenwa, R. Jagan, Inorg. Nano-Met. 2017,
17. D. S. Yanick Gaelle, M. Ondoh Agwara, D. M. 47, 618-625.
Yufanyi, J. Nenwa, R. Jagan, Inorg. Nano-Met. 2017, 40. A. M. Ajlouni, Q. Abu-Salem, Z. A. Taha, A. K.
47, 618-625. Hijazi, W. Al Momani, J. Rare Earths 2016, 34, 986-
18. P. Yang, D. -D. Zhang, Z. -Z. Wang, H. -Z. Liu, Q. -S. 993.
Shi, X. -B. Xie, Dalton Trans. 2019, 48, 17925-17935. 41. Y. Y. Zhang, N. Ren, S. L. Xu, J. J. Zhang, D. H.
19. D. H. Cai, C. L. Zhang, Q. Y. Liu, L. He, Y. J. Liu, Y. Zhang, J. Mol. Struct. 2015, 1081, 413-425.
H. Xiong, X. Y. Le, Eur. J. Med. Chem. 2021, 213, 42. M. A. Spackman, P. G. Byrom, Chem. Phys. Lett.
113182-113196. 1997, 267, 215-220.
20. Z. Aguilar-Jiménez, M. González-Ballesteros, S. G. 43. C. Bejaoui, I. Ameur, N. Derbel, A. Linden, S. Abid,
Dávila-Manzanilla, A. Espinoza-Guillén, L. Ruiz- J. Mol. Struct. 2018, 1166, 7-14.
Azuara, Int. J. Mol. Sci. 2022, 23, 12756-12778. 44. S. Gao, M. Huang, Z. Sun, D. Li, C. Xie, L. Feng, S.
21. L. Zapała, M. Kosińska, E. Woźnicka, Ł. Byczyński, Liu, K. Zheng, Q. Pang, J. Mol. Struct. 2021, 1225,
W. Zapała, J. Kalembkiewicz, Thermochim. Acta 129096-129105.
2018, 659, 242-252. 45. Z. Ude, N. Flothkötter, G. Sheehan, M. Brennan, K.
22. J. Y. Liu, N. Ren, J. J. Zhang, C. Y. Zhang, Kavanagh, C. J. Marmion, Int. J. Antimicrob. Agents
Thermochim. Acta 2013, 570, 51-58. 2021, 58, 106449-106460.
23. N. V. Somov, F. F. Chausov, I. S. Kazantseva, V. L.
Vorob'yov, M. A. E. Shumilova, A. N. Maratkanova,
J. Mol. Struct. 2022, 1270, 133935-133946.
24. I. Ameen, A. K. Tripathi, R. L. Mishra, A. Siddiqui,
U. N. Tripathi, J. Saudi Chem. Soc. 2019, 23, 725-739.
25. Y. -L. Sang, X. -S. Lin, X. -C. Li, Y. -H. Liu, X. -H.
Zhang, Inorg. Nano-Met. 2017, 47, 86-90.
26. M. Qi, W. Li, X. Zheng, X. Li, Y. Sun, Y. Wang, C.
Li, L. Wang, Front. Mater. Sci. 2020, 7, 213-239.
27. M. Jakupec, P. Unfried, B. Keppler, Reviews of
Physiology, Biochem. Pharmacol. 2005, 101-111.
28. P. Nunes, I. Correia, F. Marques, A. P. Matos, M. M.
Dos Santos, C. G. Azevedo, J. -L. Capelo, H. M.
Santos, S. Gama, T. Pinheiro, Inorg. Chem. 2020, 59,
9116-9134.
29. Y. Wang, C. -W. Jin, S. -M. He, N. Ren, J. -J. Zhang,
J. Mol. Struct. 2016, 1125, 383-390.